0001680048-17-000004.txt : 20170412 0001680048-17-000004.hdr.sgml : 20170412 20170412124552 ACCESSION NUMBER: 0001680048-17-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170412 DATE AS OF CHANGE: 20170412 EFFECTIVENESS DATE: 20170412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MUSTANG BIO, INC. CENTRAL INDEX KEY: 0001680048 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473828760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0312 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-284600 FILM NUMBER: 17757502 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 7816524507 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 D 1 primary_doc.xml X0707 D LIVE 0001680048 MUSTANG BIO, INC. 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY NEW YORK 10014 7816524507 DELAWARE Mustang Therapeutics, Inc. None Corporation true 2015 Michael S. Weiss c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Director Lindsay A. Rosenwald c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Neil Herskowitz c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Biotechnology Decline to Disclose 06b false 2017-03-31 false true true false 0 National Securities Corporation 7569 National Securities Corporation 7569 410 Park Avenue 14th Floor New York NY NEW YORK 10022 All States false 416000 416000 0 false 7 45600 0 In addition to the cash commission above, Issuer also issued warrants to purchase a number of shares of the Issuer's Common Stock equal to 10% of the aggregate amount of shares into which the Notes sold in the offering eventually are convertible. 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false MUSTANG BIO, INC. /s/ Michael S. Weiss Michael S. Weiss President and Chief Executive Officer 2017-04-12